Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.

 

Important Public Notice: ANCC Magnet Recognition Program® - Site Visit through November 4, 2022. Click here to learn more.

MENU

Fox Chase Cancer Center News

Fox Chase Cancer Center West building and a fountain outside
June 30, 2022

Fox Chase Cancer Center Welcomes Dr. Saba Shaikh

PHILADELPHIA (June 30, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Saba Shaikh, MD, as an assistant professor in the Department of Hematology/Oncology, where she will be caring for gastrointestinal and breast cancer patients.

Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center
June 29, 2022

Dr. Jaye Gardiner Receives a 2022 Eddie Méndez Award, Which Honors Underrepresented Scientists

PHILADELPHIA (June 29, 2022)—Jaye Gardiner, PhD, a postdoctoral fellow at Fox Chase Cancer Center, is one of 10 recipients of the 2022 Dr. Eddie Méndez Award, which honors underrepresented postdoctoral researchers from across the U.S. who have research expertise in cancer, infectious disease, and basic science.

Kimberly Berman, Valerie Heron, Nicolas Hoover, Carol Shellock, Christa Shine, Maureen Sims
June 24, 2022

Fox Chase East Norriton Nurses Receive 2022 Excellence in Nursing Award From Main Line Today

PHILADELPHIA (June 24, 2022)—Main Line Today has honored six Fox Chase Cancer Center – East Norriton nurses with their 2022 Excellence in Nursing Award. These exceptional professionals were nominated for their dedication and contributions throughout 2021. Fellow nurses from the region voted on the selections.

 

Sameer Patel, MD, FACS, chief of the Division of Plastic & Reconstructive Surgery at Fox Chase Cancer Center
June 24, 2022

Fox Chase Cancer Center’s Dr. Sameer Patel Inducted Into American Association of Plastic Surgeons

PHILADELPHIA (June 24, 2022)—Sameer Patel, MD, FACS, chief of the Division of Plastic & Reconstructive Surgery at Fox Chase Cancer Center, was recently inducted into the American Association of Plastic Surgeons (AAPS).

David Wiest, PhD, lead author on the study and co-leader of the Blood Cell Development and Function research program at Fox Chas
June 23, 2022

Fox Chase Researchers Find New Possible Drug Target Using Pathway Involved in Tumor Development

PHILADELPHIA (June 23, 2022)—Fox Chase Cancer Center researchers have shown in a recent study that taking a new approach to targeting a well-established cancer-promoting pathway may be effective in stopping the progression of certain cancers.

Erica Huelsmann, MD, a Gynecological Oncology Fellow at Fox Chase Cancer Center
June 21, 2022

Dr. Erica Huelsmann Wins a Conquer Cancer Annual Meeting Merit Award

PHILADELPHIA (June 21, 2022)—Erica Huelsmann, MD, a Gynecological Oncology Fellow at Fox Chase Cancer Center, has been awarded a 2022 Conquer Cancer Merit Award by Conquer Cancer, the ASCO Foundation. The prestigious award, given at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, supports researchers with projects that span many areas of cancer care, including precision medicine, palliative care, and breast cancer.

Daniel Geynisman, MD, the study author and chief of the Division of Genitourinary Medical Oncology at Fox Chase
June 1, 2022

Fox Chase Researchers Examine Racial Differences in Treatment and Outcomes of First-Line Therapies For Kidney Cancer

PHILADELPHIA (June 1, 2022)—African American/Black and white patients treated with similar first-line therapies for advanced kidney cancer experienced similar outcomes but different response rates, according to research from Fox Chase Cancer Center that will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Michael J. Hall, MD, MS, lead author on the study and chair of the Department of Clinical Genetics at Fox Chase Cancer Center
June 1, 2022

Fox Chase Researchers Explore Ancestry-Specific Genetic Risk for Triple-Negative Breast Cancer

PHILADELPHIA (June 1, 2022)—Although women of African descent experience higher incidence and mortality from triple-negative breast cancer (TNBC) than women of other races or ethnicities, a recent study shows that the magnitudes of gene-specific risks of TNBC were similar across different racial/ethnic groups. Results from the study will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Pages

Connect with Fox Chase